Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Updated Date: Thu, 11 Jun 2020 00:00:00 EDT

Ultragenyx’s Crysvita scores FDA nod in 2nd ultra-rare bone disorder kblankenship Thu, 06/18/2020 – 14:03

A High Court Judge has declared that doctors who face misconduct charges at medical practitioners tribunals should not […]

The UK has launched its subscription style payment model for antibiotics, with the first two drugs to be […]

Scientists develop AI-based tool to predict adverse drug events. Such events are responsible for some 2 million U.S. […]

One of the largest problems with cancer treatment is the development of resistance to anticancer therapies. A research […]